Actos (pioglitazone) is a pharmaceutical drug prescribed to Type II diabetics which has been found to increase a patient's risk of developing bladder cancer. Two different FDA Actos bladder cancer warnings have been issued, stating that taking the drug for one year increases the risk of bladder cancer. The drug has been recalled in other countries, but is still being prescribed to patients in the United States.
Early clinical testing revealed that Actos posed a heightened risk for blader cancer, yet the drug company did not add a warning concerning Actos bladder cancer. As one of the most prescribed diabetes drugs ever, Actos brought Takeda Pharmaceuticals millions in profits. Unaware of the risk, countless Americans developed bladder cancer while taking Actos.
In October of 2015, Takeda Pharmaceuticals offered a settlement of $2.4 billion to settle more than 9,000 pending Actos bladder cancer lawsuits. Persons who have been diagnosed with bladder cancer and have a history of taking Actos, and family members who have lost a loved one to Actos bladder cancer, are among the plaintiffs. These attorneys are still accepting new claims from persons and family members affected by bladder cancer from Actos. Filing an Actos bladder cancer lawsuit is your means to exercise your legal rights and recover damages for losses and harm resulting from the disease.
This site features general information about Actos bladder cancer lawsuits. To speak with an attorney handling national* Actos lawsuits for bladder cancer, complete the contact form for a free, no-obligation Actos cancer lawsuit case review.
Actos bladder cancer is a risk for anyone who has used the diabetes drug Actos, especially patients who took this drug for more than a year. Takeda Pharmaceuticals has knowingly exposed consumers to an increased risk of developing deadly bladder cancer, continuing to market the drug even after the FDA released a safety warning on Actos bladder cancer and following an Actos recall in France.
The FDA issued two warnings on the risk of bladder cancer from taking Actos, in 2010 and 2011. Federal regulators required that Takeda Pharmaceuticals add a bladder cancer warning label to the drug in 2011. Read detailed information about FDA bladder cancer warnings here.
Persons and the family members of persons who have suffered from bladder cancer after being exposed to pioglitazone, the active ingredient in Actos, may still qualify to file an Actos bladder cancer lawsuit. Contact these attorneys to learn about contingency representation â€“ you'll never pay a legal fee unless they win on your behalf.
This page contains answers to questions commonly asked regarding an Actos bladder cancer lawsuit, such as, Who can file an Actos bladder cancer lawsuit? and What how much does it cost to file an Actos cancer lawsuit?
Our attorneys specialize in holding large corporations accountable when they've placed profits ahead of safety. Through settlements and winning verdicts, our attorneys have obtained millions for our clients. Let us help you today. Read more about Actos Bladder Cancer Attorneys.
A leader in cancer research at Harvard University asserts that perhaps 10,000 cases of ovarian cancer can be blamed each year on perineal talc use in the US. Despite the existence of evidence that talc-based products are dangerous and can cause cancer, talc is not regulated in the US. The American Cancer Society estimates that in 2013, about 22,240 new cases of ovarian cancer will be diagnosed, while 14,030 women will die as a result of ovarian cancer in the US.
Paraquat is a highly toxic herbicide that has has been linked to an increased risk of Parkinson's disease. Used by farmers and landscapers, Paraquat is so deadly that a license is required to use it. Paraquat has been banned in 32 countries due to it's extrerme toxicity and the healh risks that come with exposure. Those who have been diagnosed with Parkinson's disease after being exposed to Paraquat may be eligible to file a Paraquat Parkinson's lawsuit.
Philips Respironics recalled over 3 million CPAP, BiPAP and ventilator machines in June of 2021, informing patients that the foam padding breaks down, leading to an array of health problems including cancer. Millions of Americans have been unknowingly exposed to cancer and other problems by a device meant to maintain their health. Those who were diagnosed with cancer or other health issues may be entitled to file a Philips CPAP, BiPAP or ventilator claim.